Connection

John Lettieri to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications John Lettieri has written about Protein Kinase Inhibitors.
John Lettieri
Connection Strength
0.122
Protein Kinase Inhibitors
  1. No Effect of Levothyroxine and Levothyroxine-Induced Subclinical Thyrotoxicosis on the Pharmacokinetics of Sorafenib in Healthy Male Subjects. Thyroid. 2017 09; 27(9):1118-1127.
    View in: PubMed
    Score: 0.122
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.